Correction to: New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagozdzon, Pawel Wisniewski
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCAR-T cell therapy research · Biosimilars and Bioanalytical Methods · Monoclonal and Polyclonal Antibodies Research
Correction to: Cancer Immunol Immunother. 2024 Jan 27;73(2):30. 10.1007/s00262-023-03602-4
In the original version of this article, the affiliation ‘’Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences, 5 Pawinskiego Street, 02–106 Warsaw, Poland’’ for author Magdalena Winiarska was missing and e-mail address for author Magdalena Winiarska were incorrectly given as [email protected] but should have been [email protected].